scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0022-3476(00)70109-0 |
P698 | PubMed publication ID | 10657833 |
P2093 | author name string | K Onel | |
T J Lehman | |||
P2860 | cites work | The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 |
Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis | Q34244145 | ||
Growth and endocrine function in children receiving long-term steroid therapy for renal disease | Q37953503 | ||
Ischemic heart disease in systemic lupus erythematosus in the young patient: report of six cases | Q39564600 | ||
Systemic lupus erythematosus in childhood: clinical manifestations and improved survival in fifty-five patients | Q40232291 | ||
A practical guide to systemic lupus erythematosus. | Q40417130 | ||
Osteopenia in patients with rheumatic diseases: principles of diagnosis and therapy | Q40620680 | ||
Remission of lupus nephritis with cyclophosphamide and late relapses following therapy withdrawal | Q40664132 | ||
Systemic lupus erythematosus in children: the complex problems of diagnosis and treatment encountered in 101 such patients at the Mayo Clinic | Q40880799 | ||
Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis | Q43918124 | ||
Cognitive effects of corticosteroids | Q46365917 | ||
Intermittent intravenous cyclophosphamide therapy for lupus nephritis. | Q54352606 | ||
The Effect of Cyclophosphamide Pulses on Fertility in Patients With Lupus Nephritis | Q67470042 | ||
Systemic lupus erythematosus within the first two decades of life | Q67544598 | ||
Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs | Q68859513 | ||
Effect of treatment on the evolution of renal abnormalities in lupus nephritis | Q71438057 | ||
Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial | Q71553667 | ||
New York University/Hospital for Joint Diseases experience with intravenous cyclophosphamide treatment: efficacy in steroid unresponsive lupus nephritis | Q72345760 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | systemic lupus erythematosus | Q1485 |
P304 | page(s) | 243-247 | |
P577 | publication date | 2000-02-01 | |
P1433 | published in | The Journal of Pediatrics | Q7743611 |
P1476 | title | Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus | |
P478 | volume | 136 |
Q39418115 | A comparative study of two intensified pulse cyclophosphamide remission-inducing regimens for diffuse proliferative lupus nephritis: an Egyptian experience. |
Q83694284 | Addition of mizoribine to the prednisolone plus tacrolimus treatment regimen in a patient with lupus flare |
Q39010807 | Advances in the care of children with lupus nephritis |
Q51869354 | Association of cyclophosphamide use with dental developmental defects and salivary gland dysfunction in recipients of childhood antineoplastic therapy. |
Q38638596 | Combination therapy of rituximab and mycophenolate mofetil in childhood lupus nephritis |
Q34095231 | Cyclophosphamide and lupus nephritis: when, how, for how long? |
Q44407318 | Cyclophosphamide therapy for lupus nephritis: poor renal survival in Arab children |
Q33366672 | Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt |
Q46091413 | Fatal infection in children with lupus nephritis treated with intravenous cyclophosphamide |
Q46602225 | Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children |
Q45270516 | Infantile systemic lupus erythematosus presenting with pulmonary hemorrhage |
Q37298723 | Intravenous cyclophosphamide combined with steroids in pediatric onset severe lupus nephritis |
Q26849746 | Juvenile systemic lupus erythematosus: review of clinical features and management |
Q35591764 | Lupus nephritis in childhood: a review of 53 patients followed at a single center |
Q42619537 | Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients |
Q43959861 | Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine |
Q33723511 | Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? |
Q36530181 | Pharmacotherapy of lupus nephritis in children: a recommended treatment approach |
Q37497048 | Prolonged improvement of childhood onset systemic lupus erythematosus following systematic administration of rituximab and cyclophosphamide |
Q38374309 | Reviewing the recommendations for lupus in children |
Q45125883 | Sequential evaluation of clinical and laboratory changes amongst children suffering from lupus nephritis during intermittent intravenous cyclophosphamide therapy. |
Q43281578 | The use of low-dose cyclophosphamide followed by AZA/MMF treatment in childhood lupus nephritis |
Q39160729 | Treatment of pediatric-onset lupus nephritis: a proposal of optimal therapy. |
Q38156915 | Treatment of young patients with lupus nephritis using calcineurin inhibitors |
Q33342024 | Treatment options for juvenile-onset systemic lupus erythematosus |
Search more.